Vogt Frederick G

Vogt Frederick G is listed in filings as Interim CEO & General Counsel at Iovance Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including purchase activity. Recent filings connect the profile to Iovance Biotherapeutics, Inc. (IOVA). The current snapshot covers public activity from Jul 17, 2024 to Jun 3, 2026. Reported amounts are shown as $70.1K to $86.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.